Cas-话题@MedSci

#Cas#

304篇内容 | 1545人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1624960, encodeId=93c11624960ee, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Br J Cancer：BCAS2参与DNA双链断裂损伤修复促进前列腺癌的发生发展, objectType=article, longId=201702, objectId=d8e7201e025b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e7201e025b, replyNumber=0, likeNumber=66, createdTime=2020-10-07, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e7201e025b, moduleTitle=Br J Cancer：BCAS2参与DNA双链断裂损伤修复促进前列腺癌的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e7201e025b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624959, encodeId=609a16249598d, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证, objectType=article, longId=199959, objectId=0f4c1999594a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f4c1999594a, replyNumber=0, likeNumber=54, createdTime=2020-08-28, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f4c1999594a, moduleTitle=Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f4c1999594a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624958, encodeId=f0b91624958a6, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗, objectType=article, longId=198088, objectId=3bce19808810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bce19808810, replyNumber=0, likeNumber=72, createdTime=2020-07-28, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bce19808810, moduleTitle=Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bce19808810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624957, encodeId=cd14162495eaa, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半, objectType=article, longId=197930, objectId=d15219e930c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d15219e930c8, replyNumber=0, likeNumber=59, createdTime=2020-07-24, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d15219e930c8, moduleTitle=Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d15219e930c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624956, encodeId=c8b31624956e7, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Cell Rep：阿尔茨海默病中，凋亡蛋白caspase与Aβ诱导的突触丧失有关, objectType=article, longId=197154, objectId=d85019e15457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85019e15457, replyNumber=0, likeNumber=38, createdTime=2020-07-08, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85019e15457, moduleTitle=Cell Rep：阿尔茨海默病中，凋亡蛋白caspase与Aβ诱导的突触丧失有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85019e15457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624955, encodeId=5b9d16249557d, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Cold Spring Harb Mol Case Stud：生物信息学家利用RNA测序指导胃癌的个性化药物处方方法, objectType=article, longId=196576, objectId=0e6a1965e692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e6a1965e692, replyNumber=0, likeNumber=56, createdTime=2020-06-28, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e6a1965e692, moduleTitle=Cold Spring Harb Mol Case Stud：生物信息学家利用RNA测序指导胃癌的个性化药物处方方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e6a1965e692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624954, encodeId=a3ff1624954f0, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=SCIENCE：病毒如何规避CRISPR-Cas引起的免疫反应, objectType=article, longId=195123, objectId=b18e195123e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b18e195123e6, replyNumber=0, likeNumber=68, createdTime=2020-06-03, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b18e195123e6, moduleTitle=SCIENCE：病毒如何规避CRISPR-Cas引起的免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b18e195123e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624953, encodeId=b7401624953eb, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验, objectType=article, longId=191237, objectId=098119123ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098119123ef1, replyNumber=0, likeNumber=57, createdTime=2020-04-03, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098119123ef1, moduleTitle=CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098119123ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624952, encodeId=8bd1162495278, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Blood：特发性多中心Castleman病的mTOR激活增强, objectType=article, longId=191226, objectId=820019122655, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=820019122655, replyNumber=0, likeNumber=64, createdTime=2020-04-03, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=820019122655, moduleTitle=Blood：特发性多中心Castleman病的mTOR激活增强, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=820019122655)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624951, encodeId=d29d16249511f, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=口腔颌面颈部Castleman病：6例临床病例报告和文献复习, objectType=article, longId=190292, objectId=aa5a19029234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa5a19029234, replyNumber=0, likeNumber=53, createdTime=2020-03-20, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa5a19029234, moduleTitle=口腔颌面颈部Castleman病：6例临床病例报告和文献复习, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa5a19029234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624950, encodeId=f0c01624950c6, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=颅内Castleman病一例, objectType=article, longId=189999, objectId=d91818999998, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d91818999998, replyNumber=0, likeNumber=51, createdTime=2020-03-16, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d91818999998, moduleTitle=颅内Castleman病一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d91818999998)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624949, encodeId=448716249495c, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性, objectType=article, longId=187424, objectId=563618e4243b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=563618e4243b, replyNumber=0, likeNumber=75, createdTime=2020-02-06, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=563618e4243b, moduleTitle=Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=563618e4243b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624948, encodeId=eca8162494850, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功, objectType=article, longId=186029, objectId=4575186029eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4575186029eb, replyNumber=0, likeNumber=102, createdTime=2020-01-11, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4575186029eb, moduleTitle=ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4575186029eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624947, encodeId=4e0b162494efb, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, objectType=article, longId=185698, objectId=7e00185698b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e00185698b8, replyNumber=0, likeNumber=63, createdTime=2020-01-06, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e00185698b8, moduleTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e00185698b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624946, encodeId=ce79162494649, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, objectType=article, longId=185466, objectId=155d185466bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=155d185466bf, replyNumber=0, likeNumber=58, createdTime=2020-01-01, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=155d185466bf, moduleTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=155d185466bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624945, encodeId=74581624945cf, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, objectType=article, longId=185405, objectId=309b18540526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=309b18540526, replyNumber=0, likeNumber=36, createdTime=2019-12-31, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=309b18540526, moduleTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=309b18540526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624944, encodeId=e2b31624944c1, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=手把手教你写Case report，发表SCI文章, objectType=article, longId=184929, objectId=f7b5184929bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b5184929bf, replyNumber=0, likeNumber=34, createdTime=2019-12-20, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b5184929bf, moduleTitle=手把手教你写Case report，发表SCI文章, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b5184929bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624943, encodeId=f3221624943f1, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, objectType=article, longId=184737, objectId=5df1184e3771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df1184e3771, replyNumber=0, likeNumber=82, createdTime=2019-12-15, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df1184e3771, moduleTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df1184e3771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624942, encodeId=f2741624942b4, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, objectType=article, longId=183489, objectId=74b918348978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b918348978, replyNumber=0, likeNumber=75, createdTime=2019-11-25, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b918348978, moduleTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b918348978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624941, encodeId=61c51624941e7, content=<a href='/topic/show?id=0333412062' target=_blank style='color:#2F92EE;'>#Cas#</a>, objectTitle=BMC Gastroenterology：caspase-1在乙肝中的不同表达可作为急性慢性肝衰竭的生物标志物, objectType=article, longId=183378, objectId=bd311833e872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd311833e872, replyNumber=0, likeNumber=30, createdTime=2019-11-23, rootId=0, userName=yaanren, userId=411420689333, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd311833e872, moduleTitle=BMC Gastroenterology：caspase-1在乙肝中的不同表达可作为急性慢性肝衰竭的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd311833e872)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Cas

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#Cas#

Br J Cancer：BCAS2参与DNA双链断裂损伤修复促进前列腺癌的发生发展

2020-10-07

yaanren (审核中...)

前往app查看评论内容

#Cas#

Nat BME:基于Cas13的SARS-CoV-2RNA检测方法的临床验证

2020-08-28

yaanren (审核中...)

前往app查看评论内容

#Cas#

Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗

2020-07-28

yaanren (审核中...)

前往app查看评论内容

#Cas#

Science：科学家发现新型基因编辑工具，体积是CRISPR-Cas9的一半

2020-07-24

yaanren (审核中...)

前往app查看评论内容

#Cas#

Cell Rep：阿尔茨海默病中，凋亡蛋白caspase与Aβ诱导的突触丧失有关

2020-07-08

yaanren (审核中...)

前往app查看评论内容

#Cas#

Cold Spring Harb Mol Case Stud：生物信息学家利用RNA测序指导胃癌的个性化药物处方方法

2020-06-28

仁医06 (审核中...)

前往app查看评论内容

#Cas#

SCIENCE：病毒如何规避CRISPR-Cas引起的免疫反应

2020-06-03

yaanren (审核中...)

前往app查看评论内容

#Cas#

CRISPR / Cas9疗法OTQ923治疗镰状细胞疾病：FDA已批准进行临床试验

2020-04-03

yaanren (审核中...)

前往app查看评论内容

#Cas#

Blood：特发性多中心Castleman病的mTOR激活增强

2020-04-03

yaanren (审核中...)

前往app查看评论内容

#Cas#

口腔颌面颈部Castleman病：6例临床病例报告和文献复习

2020-03-20

yaanren (审核中...)

前往app查看评论内容

#Cas#

颅内Castleman病一例

2020-03-16

yaanren (审核中...)

前往app查看评论内容

#Cas#

Lancet haematol：硼替佐米治疗特发性多中心Castleman病的长期安全性

2020-02-06

yaanren (审核中...)

前往app查看评论内容

#Cas#

ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功

2020-01-11

yaanren (审核中...)

前往app查看评论内容

#Cas#

Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症

2020-01-06

yaanren (审核中...)

前往app查看评论内容

#Cas#

PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用

2020-01-01

yaanren (审核中...)

前往app查看评论内容

#Cas#

J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效

2019-12-31

yaanren (审核中...)

前往app查看评论内容

#Cas#

手把手教你写Case report，发表SCI文章

2019-12-20

yaanren (审核中...)

前往app查看评论内容

#Cas#

Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应

2019-12-15

yaanren (审核中...)

前往app查看评论内容

#Cas#

Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据

2019-11-25

yaanren (审核中...)

前往app查看评论内容

#Cas#

BMC Gastroenterology：caspase-1在乙肝中的不同表达可作为急性慢性肝衰竭的生物标志物

2019-11-23

科室
- - 订阅+
  - 更多科室
工具
服务